Jasmin Pernille Hjerresen

Jasmin Pernille Hjerresen

Auto-generated profile, based on publicly available information

Jasmin Pernille Hjerresen

Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2025 in Nature
Verified
Journal Article
Open access
PDF file
FSFrederik Filip Stæger
Frederik Filip Stæger
MAMette K. Andersen
Mette K. Andersen
ZLZilong Li
Zilong Li
JHJasmin Pernille Hjerresen
Jasmin Pernille Hjerresen
SHShixu He
Shixu He
AAAnders Albrechtsen
Anders Albrechtsen
Greenlandic Inuit and other indigenous populations are underrepresented in genetic research1,2, leading to inequity in healthcare opportunities. To address this, we performed analyses of sequenced or imputed genomes of 5,996 Greenlanders with extensive phenotypes. We quantified their historical population bottleneck and how it has shaped their genetic architecture to have fewer, but more common, variable sites. Consequently, we find twice as many high-impact genome-wide associations to metabolic traits in Greenland compared with Europe. We infer that the high-impact variants arose after the population split from Native Americans and thus are Arctic-specific, and show that some of them are common due to not only genetic drift but also selection. We also find that European-derived polygenic scores for metabolic traits are only half as accurate in Greenlanders as in Europeans, and that adding Arctic-specific variants improves the overall accuracy to the same level as in Europeans. Similarly, lack of representation in public genetic databases makes genetic clinical screening harder in Greenlandic Inuit, but inclusion of Greenlandic data remedies this by reducing the number of non-causal candidate variants by sixfold. Finally, we identify pronounced genetic fine structure that explains differences in prevalence of monogenic diseases in Greenland and, together with recent changes in mobility, leads to a predicted future reduction in risk for certain recessive diseases. These results illustrate how including data from Greenlanders can greatly reduce inequity in genomic-based healthcare.

6 April 2026 in Ophthalmology Science
Verified
Journal Article
Open access
KTKajetan Trošt
Kajetan Trošt
QGQian Gao
Qian Gao
JHJasmin Pernille Hjerresen
Jasmin Pernille Hjerresen
PPPorntiva Poorisrisak
Porntiva Poorisrisak
MBMia Ortved Bjerager
Mia Ortved Bjerager
Carina SlidsborgCarina Slidsborg
Carina Slidsborg
Retinopathy of prematurity (ROP) is a multifactorial eye disease affecting children born premature and is a leading cause of blindness in preterm infants worldwide. Although it has primarily been associated with high oxygen supplementation from respiratory support, there are indications that additional metabolic factors, like circulating lipids, may play a role in the disease’s pathophysiology. An exploratory study on the development of ROP in preterm infants was conducted in Denmark during 2018 and 2019. Infants who developed a maximum of stage 1 ROP were classified as having mild retinopathy, whereas those who developed stage 2 or 3 were classified as having severe retinopathy. The study involved 110 preterm infants born before 32 weeks of gestational age. During hospitalization in the neonatal wards, the infants were screened for ROP, and blood samples were collected every 2 weeks. A total of 485 lipid species were analyzed using lipidomics methodology, and mixed linear models were applied. The association of lipids in early life (postnatal weeks 3–4) and their change throughout the study period was investigated. All lipid classes, involving 310 lipid species, changed significantly during the neonatal period. In early postnatal life, the lipid profiles of some classes (especially phosphatidylcholines and ether-linked phosphatidylcholines) were associated with the severity of ROP. In infants with stage 2 or 3 ROP, glycerophospholipids and sphingolipids changed more slowly compared with infants with no ROP. Similarly, glycerophospholipid pathways were enriched in infants with ROP. The lipidomic plasma profile in preterm infants shows significant change across the neonatal period, involving all lipid classes. The association with ROP suggests that lipid metabolism may also play a role in ROP pathogenesis. Dyslipidemia associated with ROP should be addressed in further studies. The authors have no proprietary or commercial interest in any materials discussed in this article.

1 November 2025 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
SRStina Ramne
Stina Ramne
TSTeresa Duarte da Costa Seco
Teresa Duarte da Costa Seco
KKKatharina Barbara Kuentzel
Katharina Barbara Kuentzel
TGTrisha J. Grevengoed
Trisha J. Grevengoed
JHJasmin P. Hjerresen
Jasmin P. Hjerresen
NGNiels Grarup
Niels Grarup
The hepatic hormone FGF21 is regulated by dietary intake. The results of this human meal study suggest that coconsumption of protein inhibits alcohol-induced FGF21 secretion in humans, similar to how protein intake previously has been shown to inhibit sugar-induced FGF21 secretion. This indicates that dietary protein is a consistent downregulator of FGF21. We found no indication that intake of retinol influences FGF21 regulation.

28 September 2026 in ChemRxiv
Verified
Preprint
Open access
MAMatthias Anagho-Mattanovich
Matthias Anagho-Mattanovich
OHOndrej Hodek
Ondrej Hodek
ABAiko Barsch
Aiko Barsch
NKNikolas Kessler
Nikolas Kessler
SWSofie Weinkouff
Sofie Weinkouff
TMThomas Moritz
Thomas Moritz

29 June 2026 in ChemRxiv
Verified
Preprint
Open access
MAMatthias Anagho-Mattanovich
Matthias Anagho-Mattanovich
OHOndrej Hodek
Ondrej Hodek
ABAiko Barsch
Aiko Barsch
NKNikolas Kessler
Nikolas Kessler
SWSofie Weinkouff
Sofie Weinkouff
TMThomas Moritz
Thomas Moritz